Sweet's syndrome in a severely neutropenic patient during therapy with recombinant human granulocyte colony-stimulating factor

Journal of the Formosan Medical Association

Volumn 96, Issue 4, 1997, Pages 276-279

  Chao, Sheau Chiou ^a,b   Lee, J Yu Yun ^a   Tsao, Chao Jung ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

acute myelogenous leukemia; neutropenia; recombinant human granulocyte colony stimulating factor; Sweet's syndrome

Indexed keywords

AMIKACIN; AMPHOTERICIN B; CEFTAZIDIME; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; OXACILLIN; PIPERACILLIN; PREDNISOLONE; TOBRAMYCIN; VANCOMYCIN;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CASE REPORT; HUMAN; MALE; NEUTROPENIA;

GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; NEUTROPENIA; SWEET'S SYNDROME;

EID: 0030947686     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Galbrilove J: The development of granulocvte colony-stimulating factor in its various clinical applications. Blood 1992;80:1382-5.
2. Lieschke GJ, Burgess AW: Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. New Engl J Med 1992;327:28-35.
3. Ross HG, Mov LA, Kaplan R, et al: Bullous pvoderma gangrenosum after granulocvte colony-stimulating factor treatment. Cancer 1991;68:441-3.
4. Ostlere LS, Harris D, Prentice HG, et al: Widespread folliculitis induced by human granulocyte-colony-stimulating factor therapy. Br J Dermatol 1992;127.193-4.
5. Negrin RS, Haenber DH, Nagler A, et al: Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. Ann Intern Med 1989;110:976-84.
6. Sweet RD: An acute febrile neutrophilic dermatosis. Br J Dermatol 1964;76:349-56.
7. Kemmett D, Hunter JA: Sweet's syndrome: a clinicopathologic review of twenty-nine cases. J Am Acad Dermatol 1990;23:503-7.
8. Cohn PR, Talpaz M, Kurzrock R: Malignancy-associated Sweet's syndrome: review of the world literature. J Clin Oncol 1988;6:1887-97.
9. Cohen PR, Kurzrock R: Sweet's syndrome and malignancy. Am J Med 1987;82:1220-6.
10. Greer KE, Cooper PH: Sweet's syndrome (acute febrile neutrophilic dermatosis). Clin Rheum Dis 1982;8:427-41.
11. Glaspy JA, Baldwin GC, Robertson PA, et al: Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor. Ann Intern Med 1988;109:789-95.
12. Park JW, Mehrotra B, Barnett BO, et al: The Sweet syndrome during therapy with granulocyte colony-stimulating factor. Ann Intern Med 1992;116:996-8.
13. MoriokaN, Otsuka F, Nogita T, et al: Neutrophilic dermatosis with myelodysplastic syndrome: nuclear segmentation anomalies of neutrophils in the skin lesion and in peripheral blood. J Am Acad Dermatol 1990;23:247-9.
14. Paydas S, Sahin B, Seyrek E, et al: Sweet's syndrome associated with G-CSF. Br J Haematol 1993;85:191-2.
15. Fukutoku M, Shimizu S, Ogawa Y, et al: Sweet's syndrome during therapy with granulocyte colony-stimulating factor in a patient with aplastic anaemia. Br J Haematol 1994;86:645-8.
16. Van Kamp H, Van Den Berg E, Timens W, et al: Sweet's syndrome in myeloid malignancy: a report of two cases. Br J Haematol 1994;86:415-7.
17. Shimizu T, Yoshida I, Eguchi H, et al: Sweet syndrome in a child with aplastic anemia receiving recombinant granulocyte colony-stimulating factor. J Pediatr Hematol Oncol 1996;18:282-4.
18. Jain KK: Sweet's syndrome associated with granulocyte colony-stimulating factor. Cutis 1996;57:107-10.
19. Garty BZ, Levy I, Nitzan M, et al: Sweet syndrome associated with G-CSF treatment in a child with glycogen storage disease type Ib. Pediatrics 1996;97:401-3.
20. Suzuki Y, Kuroda K, Kojima T, et al: Unusual cutaneous manifestations of myelodysplastic syndrome. Br J Dermatol 1995;133:483-6.
21. Reuss-Borst MA, Pawelec G, Saal JG, et al: Sweet's syndrome associated with myelodysplasia: possible role of cytokines in the pathogenesis of the disease. Br J Haematol 1993;84:356-8.
22. Cox G, Gauldie J, Jordana M: Bronchial epithelial cell-derived cytokines (G-CSF and GM-CSF) promote the survival of peripheral blood neutrophils in vitro. Am J Respir Cell Mol Biol 1992;7:507-13.
23. Rapoport AP, Abboud CN, DiPersio JF: Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF): receptor biology, signal transduction, and neutrophil activation. Blood Rev 1992;6:43-57.
24. Gordon MS, Nemunaitis J, Hoffman R, et al: A phase I trial of recombinant human interleukin-6 in patients with myelodysplastic syndrome and thrombocytopenia. Blood 1995;85:3066-76.
25. van Gameren MM, Willemse PH, Mulder NH, et al: Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study. Blood 1994;84:1434-41.